The Prostate Profile measures prostate-specific antigen (PSA) levels, free PSA, and the ratio between them, offering valuable insights into prostate health.

Prostate cancer is the most common form of cancer in men, and while PSA testing alone cannot provide a definitive diagnosis, elevated or abnormal results warrant further medical evaluation.

This test is suitable for both finger-prick and blood draw (phlebotomy) samples.

The Prostate Profile test (Total & Free PSA) is a blood test designed to measure two types of prostate-specific antigens (PSA) in your bloodstream. The prostate gland, located below the bladder in men, produces PSA, and this test helps assess the health of the prostate.

This test is commonly used in the early detection of prostate cancer and is also useful in monitoring individuals with an existing prostate cancer diagnosis.

The Prostate Profile measures both total PSA and free PSA. Total PSA reflects the overall amount of PSA in the blood, while free PSA measures the portion of PSA that is not bound to proteins. By evaluating the ratio between these two forms, healthcare providers can gain better insights into the likelihood of prostate cancer.

Elevated PSA levels can result from various factors, including recent ejaculation, benign prostate enlargement, or inflammation. To avoid misleading results, it’s recommended to wait 48 hours after ejaculation before taking the test.

It’s important to note that while this test can provide valuable information, it is not always definitive. Regular testing can help track changes over time, which may offer better insights into prostate health. However, elevated PSA levels do not always indicate cancer, and cancer can sometimes be present even with normal PSA levels.

This test is most often recommended for men over 50 or those with a family history of prostate cancer, as regular monitoring can help detect any significant changes in PSA levels.